Navigation Links
New Study Results Published in the New England Journal of Medicine Show Dabigatran Etexilate Mesylate Reduces the Risk of Recurrent Venous Thromboembolism
Date:2/20/2013

ative risk reduction 46 percent; p<0.001)
  • Trend toward lower risk of major bleeding alone: 13 patients, 0.9 percent versus 25 patients,1.8 percent (relative risk reduction 48 percent; p=0.06)
  • A higher rate of acute coronary syndrome (ACS) events was observed in the dabigatran group versus warfarin (13 patients, 0.9 percent versus three patients, 0.2 percent, respectively; p=0.02)
  • RE-SONATE

    • Design: 1,343 patients randomized to dabigatran 150 mg (681 patients) or placebo (662 patients) for six months with extended follow-up to evaluate the long-term risk of recurrence (12 months after completion of study treatment)
    • Efficacy: 92 percent risk reduction for recurrent or fatal VTE with dabigatran versus placebo (three patients, 0.4 percent versus 37 patients, 5.6 percent; p<0.001 for superiority)
    • Safety: the incidence of major bleeding was two patients in the dabigatran group versus zero patients in the placebo group. A higher rate of major or clinically relevant bleeding in the dabigatran group versus no treatment was observed (36 patients, 5.3 percent versus 12 patients, 1.8 percent; p=0.001)

    * Pradaxa® (dabigatran etexilate mesylate) capsules are not approved by the U.S. Food and Drug Administration for the prevention of recurrent VTE or the treatment of acute VTE.

    About Pradaxa® (dabigatran etexilate mesylate) Capsules

    Indications and Usage
    Pradaxa® (dabigatran etexilate mesylate) capsules is indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

    IMPORTANT SAFETY INFORMATION ABOUT PRADAXA

    CONTRAINDICATIONS
    PRADAXA is contraindicated in patients with:

    • Active pathological bleeding
    • A known serious hypersensitivity rea
      '/>"/>

    SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
    2. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
    3. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
    4. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
    5. Shingles Vaccine is Safe, According to New Study
    6. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
    7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
    8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
    9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
    10. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
    11. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2015)... , July 29, 2015 Alvarado ... 23, called the Alvarado Spine & Joint Institute. ... and rehabilitation, focusing on spinal surgery and joint ... patient care takes a patient experience-focused approach. For ... they feel comfortable in, rather than patient gowns. ...
    (Date:7/29/2015)... --  Turing Pharmaceuticals AG announced today that ... its first Chief Communication Officer. In this ... internal and external communications and will provide counsel to ... to Founder and Chairman, Martin Shkreli , and ... "We are excited to have Craig join Turing and ...
    (Date:7/29/2015)... , July 27, 2015 Research ... addition of the "Global Neurostimulation Devices Market ... The analysts forecast the global neurostimulation devices market ... the period 2014-2019. The report, Global ... on an in-depth market analysis with inputs from ...
    Breaking Medicine Technology:The Alvarado Spine & Joint Institute Opens July 30 in San Diego 2Turing Pharmaceuticals Names Craig Rothenberg Chief Communication Officer 2Turing Pharmaceuticals Names Craig Rothenberg Chief Communication Officer 3Global Neurostimulation Devices Market 2015-2019 2
    ... 2007 /PRNewswire/ -- Alfacell,Corporation today announced that ... officer and corporate secretary, will,present an overview ... a.m. EDT on Thursday, July 12, 2007, ... Conference in New York. , The audio ...
    ... and NORTH BRUNSWICK, New Jersey, July 03, 2007,/PRNewswire-FirstCall/ ... announced today that J. Michael French, Rosetta Genomics,President, ... Conference on Tuesday, July 10, at 11:00 am ... , A live audio webcast of the presentation ...
    Cached Medicine Technology:Alfacell Corporation to Present at C.E. Unterberg, Towbin Emerging,Growth Opportunities Conference 2Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin,Emerging Growth Opportunities Conference 2
    (Date:7/29/2015)... ... 2015 , ... Potomac Pilates, an elite Washington, D.C. metro area-based Pilates studio, ... ® by Potomac Pilates. On Thursday, July 30, Potomac Pilates will unveil its ... Potomac Pilates will continue to offer the same classes and personal experiences their clients ...
    (Date:7/29/2015)... ... July 29, 2015 , ... ... educators and service providers of children living with autism will converge upon Penn ... growing demographic. , The National Autism Conference will be held Aug. 3-6 ...
    (Date:7/29/2015)... ... 29, 2015 , ... The NCCA re-accredited the Commission for ... 30, 2019, during its recent meeting. , The Commission received renewal of NCCA ... with the NCCA’s Standards for the Accreditation of Certification Programs. NCCA is ...
    (Date:7/29/2015)... ... July 29, 2015 , ... According to the Miami Herald on ... and mental health disorders. Acu-detox may begin taking off in the South Florida community ... alcohol addiction. Although acupuncture is not a new practice, it is not widely used, ...
    (Date:7/29/2015)... ... July 29, 2015 , ... Orthopedic surgeons at Lourdes Medical Center of ... Rotator Cuff System, a new implant to treat a common source of shoulder pain ... regeneration of additional tendon tissue, which could allow for faster healing and a decreased ...
    Breaking Medicine News(10 mins):Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 2Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 3
    ... Patients with idiopathic pulmonary fibrosis (IPF) are three times ... people without the disease, according to a recent study ... 1,000 patients with IPF and more than 3,500 matched ... people with IPF have roughly a three-fold increased risk ...
    ... Joe,s Sports & Outdoor stores,across the Pacific Northwest ... September for the Children,s Cancer Association (CCA). For the,third ... compassion and generosity by donating to CCA at checkout ... CCA Founder and CEO, Regina Ellis, said, "Once ...
    ... your smile goes farther than you think , , THURSDAY, Dec. ... -- and so can happy friends of your friends. , ... you and people you,ve never met can have an impact ... beyond people we,re directly connected to," said study co-author James ...
    ... MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ), today ... office in Westlake, Texas. The Company,s Germantown,facility ... including,MiddleBrook,s research and development group. The newly ... house up to 60 employees as MiddleBrook,grows. , ...
    ... standard dose of daunorubicin, study shows , , THURSDAY, Dec. ... chemotherapy drug daunorubicin prolonged survival for patients with previously ... study sponsored by the U.S. National Cancer Institute (NCI) ... and bone marrow. This study included 633 patients, aged ...
    ... on the eve of its 35th Anniversary, Ronald McDonald House Charities (RMHC) ... that a little help goes a long way. The initiative, designed to ... three core programs: Ronald McDonald House, Ronald McDonald Family Room and the ... ...
    Cached Medicine News:Health News:Double threat: Deadly lung disease also linked to heart attacks 2Health News:Joe's Sports & Outdoor In-Store Promotion Raises $18,000 for the Children's Cancer Association 2Health News:Being Happy Affects Even Those You Don't Know 2Health News:Being Happy Affects Even Those You Don't Know 3Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 2Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 3Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 4Health News:Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients 2Health News: Ronald McDonald House Charities Brings People Together Like Never Before with First-Ever, Multi-Channel Social Networking Campaign : Charity Finds New Ways to Encourage Seasonal Giving in Tough Economic Times 2Health News: Ronald McDonald House Charities Brings People Together Like Never Before with First-Ever, Multi-Channel Social Networking Campaign : Charity Finds New Ways to Encourage Seasonal Giving in Tough Economic Times 3
    BD Beaver Cataract blade, 30.0 mm long x 2.2 mm wide, designed for ICCE and ECCE procedures, designed for ICCE and ECCE, sterile....
    BD Beaver DeBakey blade, 5 mm cutting width, sterile....
    ... standard trial frames. They are made of optical quality ... box. There are two sets available providing a full ... is that a patient can wear the prism with ... the patient to adapt to the use of the ...
    Developed for reconstructive plastic surgery with E-Type coupling. Order blades by size from 12 mm, 25 mm, 50 mm or 75 mm depending on your specific case requirements. Blades come in packs of 10....
    Medicine Products: